GRWG Top is NearTime to lock in some profits? It has been a killer ride, since I first discovered this at $7. Best play of the year!
Congrats to all that followed me. This one worked out exactly as planned, which is rather rare... We caught the break out from $16-ish, and we played the entire ride up.
I sold most of my position yesterday. It looks like she has another leg in her. I am likely to cash out everything, either when she drops too much, or when we get a higher high. New entries in January, I am sure.
Happy holidays, everybody. Thanks for the hundreds of views, the 2 or 3 likes and the occasional troll. What a shit world we live in.
GRWG
GRWG Beautiful bounceWhat drove this bounce? Shorts? Bulls waiting at support? If you bought the dip, then congrats.
Today, I would like to see it regain the hourly MA21 for continuation. Alternatively, a retest of the lows at the .618 of the bounce. A typical wave 2 target.
Potential upside target zone $39 - $51. First confluence at $39.
GRWG - A Bear CaseWeighing both impending federal policy changes and strong fundamentals, GrowGeneration (GRWG) looks like a promising cannabis stock to buy & hold. With an incoming Biden administration, federal cannabis decriminalization will happen, paving the way to allow banking institutions to service the industry. While GRWG doesn’t operate in the agricultural or distribution segments of the cannabis plant (most impacted from federal banking regulations), it will benefit when legal barriers are removed. As a distributor sales channel of hydroponic equipment and consumable products used to grow cannabis, GRWG stands to benefit from a large shift in federal policy and has already benefited from state policies legalizing both medical and recreational cannabis use.
With everything good happening to the cannabis industry, I lay out a bear case for GRWG and why it should not be bought as an investment.
Executive leadership is the primary reason GRWG is uninvestable. Hindenburg Research, an activist short seller, has published findings detailing the company’s leadership indiscretions going back decades...and it’s ugly. Strong executive leadership teams should display the industry’s best business minds, squeaky clean personal backgrounds, and a track record of wins in previous business dealings. Hindenburg brings to light GRWG’s leadership’s ties to prior penny stock pump & dump schemes, various SEC entanglements, personal relationships with known persons associated with criminal syndicates, various failed business ventures, financial accounting gaps … the list goes on and on and on.
Before moving forward, let’s call a spade a spade: the purpose of Hindenburg’s research is to convince investors to sell GRWG. Hindenburg has a publicly stated short position in GRWG and has an agenda to drive the stock price down. They directly benefit from painting this company or its leadership in a negative light. One should take the research with a grain of salt when weighing its importance in a decision to buy or sell the stock.
While Hindenburg Research’s findings were enough for me to sell my position, I found this wasn’t the only red flag.
Following Bill O’Neil’s CANSLIM methodology when analyzing stocks, one of the metrics is Cash Flow per Share vs EPS. Cash Flow per Share for a great stock should be +20% greater than EPS in the same quarter. Starting with FY2019, they posted four quarters of Cash Flow per share equaling EPS; a 0% increase in Cash Flow per Share vs EPS. FY2020 was shaping up with Q1 & Q3 having both +16.6% Cash Flow per Share increases vs EPS. 2020Q2 posted a -83.3% decrease of Cash Flow per Share vs EPS. I would normally give this one miss a pass due to their strong sales growth over the past 8 quarters, increasing more than 125% (QoQ vs PY Q) and strong EPS growth over the past 6 of 7 quarters (QoQ vs PY Q) because, we’re measuring the total sum and not measuring just one metric. But, I also wanted to deep dive that 1 quarter (1 of 7) where EPS contracted. At first glance, the -700% decrease in EPS vs PY Q occurred in 2020Q1 and my first inclination was, it must have been the impact on their business due to COVID-19. I dug deeper into their 10Q and read:
The net loss for the quarter ended March 31, 2020 was primarily due to the increase in share-based compensation from approximately $80,000 in 2019 to $4.1 million for the quarter ended March 31, 2020.
…
If the new share-based awards effective January 1, 2020 were level vesting over two years and not front loaded vesting then the first quarter of 2020 expense would have been reduced by approximately $2.43 million and the first quarter of 2020 net loss would have been net income of approximately $332,000. Future periods share-based compensation would increase as a result of spreading the $2.35 million over two years, had the awards been level vested.
TRANSLATE: Management decided to bump up compensation all at once vs spreading it out over the next two years and by doing that, hurt earnings for the quarter.
What kind of forward thinking, long-term oriented management team would do that? With everything good happening in this industry, management couldn’t have taken compensation increases over the next two years in order to preserve positive momentum the in their fundamentals? I suppose spreading it out over the future 8 quarters could put stress on future earnings, but then, maybe this isn’t the time to increase compensation if it can’t be successfully managed. I get it, an increase in executive compensation after growing at an insane clip for the past 5 quarters feels earned, but great business leaders are supposed to be the harbingers of good faith with the intention of growing the stock price for all shareholders. There was no better way to increase compensation? In my opinion, this decision represents terrible judgment at worst and poor planning at best. This was red flag strike number 3.
1) Hindenburg Research
2) Cash Flow per Share vs EPS not hitting the mark
3) Management throwing a wrench into earnings, when they had the option to otherwise not, in order to benefit themselves.
For these reasons, GRWG is entirely uninvestable.
In all honesty, if we play devil’s advocate and assume everything in Hindenburg’s Research is true, that is more than enough reason to not own this stock. I encourage everyone to read it in order to familiarize themselves with what a worst case scenario looks like. The overall fundamentals in this stock look pretty damn good and even Hindenburg states, “... bulls would likely argue that the business is positioned well to consolidate its industry niche and grow into its numbers with the backing of strong management.” Unfortunately, that does not seem to be the case.
When heeding activist research, be skeptical when talking heads make claims like the those laid out in Hindenburg’s piece. They have a short position; they want the stock to go down. Gauge your own risk profile and trading style. Do your own homework.
Happy Stock Picking!
GRWG - Tough countOne of the toughest charts to count, was GRWG's sideways action after the spike, earlier this year. Currently at an upside target where confluence suggests the possibility for a top.
Chart suggests we're in a primary wave 3, though maybe looking for an intermediate wave 2 here soon. I'm staying long this asset, but will accumulate on proper dips.
**EARNINGS TOMORROW** GRWG!I love this stock so much and I took the trade at 11. Looking at them now they are primed to beat earnings with expansions happening nationwide following states legalization . Because they are a regular company, then are not effected by the lack of legalization because they've grown into what is given and can only benefit from legalization. They did well on earnings and the news feed is chock full of good shit. This is a BUY.
GRWG Earning TodayVery nice price action, but since the parabolic spike, most of it looks corrective.
I've taken a good deal of profits, but decided to play earnings with tiny position, just in case we get a FOMO spike.
Without any disruptive events in play, which means under normal circumstances, GRWG would look to a decent move to the downside, which would be a minor correction in a longer term very bullish chart.
Remember, if assets move 15% up and down regularly, they are trades, not investments.
Let us play!
Top Cannabis Stock Picks! GRWG APHA GWPH. So I have a Solid pick in $GRWG
$APHA is a great buy right now at the price and with the potential
$GWPH is a LONG hold. And strictly equity. I will be adding at key levels.
I Dont disregard the favorites like $ACB $CGC and others but I think that these offer potential as well. GWPH perhaps I am biased on because ive been watching this company for a while, but I think this goes higher based off potential and foothold
All in all federal legalization will send us flying. Id rather be in position.
Cannabis Stocks- GRWGI LOVE this company LONG. Unfortunately this is the perfect place to buy and the sketchiest place to buy. With a possible Biden win, cannabis stocks like this one will soar. Two things in GRWG's favor in the mean time is the possible legalization in 5 states. Also, earnings coming up is expected to be a good one. So if we hit all three. Biden win. Earnings hit. Legaliztion. Then i could see a strong run up as this ticker as already see some good volume in the past.